Stabilisation Notice
11 Enero 2008 - 5:31AM
UK Regulatory
RNS Number:5959L
Lehman Brothers Intl (Europe)
11 January 2008
Post-Stabilisation Disclosure
11th January, 2008
Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful.
GlaxoSmithKline Capital plc
Stabilisation Notice
Lehman Brothers International (Europe) (contact: Andre Portelli/ Kevin White;
telephone: 0207 103 8610) hereby gives notice that no stabilisation (within the
meaning of the rules of the Financial Services Authority) was undertaken by the
Stabilising Manager(s) named below in relation to the offer of the following
securities.
Issuer: GlaxoSmithKline Capital plc
Guarantor (if any): Not Applicable
Aggregate nominal amount: Euro3,500,000,000
Description: Euro 2,250,000,000 Fixed Rate Notes due 13 December 2012 &
Euro 1,250,000,000 Fixed Rate Notes due 13 December 2017
Stabilising Manager(s) Credit Suisse Securities (Europe) Limited
Deutsche Bank AG, London Branch
Lehman Brothers International (Europe)
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or dispose
of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale in the United States.
The securities have not been, and will not be, registered under the United
States Securities Act of 1933 and may not be offered or sold in the United
States absent registration or an exemption from registration. There has not
been and will not be a public offer of the securities in the United States.
This information is provided by RNS
The company news service from the London Stock Exchange
END
STABBMBTMMTBBLP
Glaxosmsc 5.25% (LSE:AG99)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Glaxosmsc 5.25% (LSE:AG99)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024